Literature DB >> 29911151

Pathological and molecular investigation of velogenic viscerotropic Newcastle disease outbreak in a vaccinated chicken flocks.

Asok Kumar Mariappan1, Palanivelu Munusamy1, Deepak Kumar2, Shyma K Latheef1, Shambu Dayal Singh1, Rajendra Singh3, Kuldeep Dhama1.   

Abstract

Newcastle disease virus (NDV) belongs to genus Avulavirus and family Paramyxoviridae. There are thirteen serotypes named APMV-I (Avian Paramyxovirus-I) to APMV-13 of which NDV has been designated as APMV-1. The disease has been reported worldwide affecting both domestic and wild avian species. Morbidity and mortality rates up to 100% have been reported in cases of unvaccinated flocks. Stringent vaccination schedule is practiced in endemic/disease prone areas in order to prevent the disease. Despite this, NDV outbreaks have been reported even in cases of vaccinated populations. In this study we describe detailed pathological and molecular investigation that were undertaken in an organized poultry farm from Bareilly region, Uttar Pradesh, India, involving layer flocks which succumbed to ND outbreak in spite of following strict vaccination protocol. The mortality rate ranged from 76.80 to 84.41% in different flocks with an average mortality of 79.50%. Necropsied birds had gross lesions suggestive of viscerotropic ND including petechial hemorrhages on the proventricular tips, intestinal lumen with necrotic areas covered with hemorrhages, hemorrhagic cecal tonsils, para-tracheal edema and mottling of spleen. The characteristic histopathological lesions were mainly seen in the blood vessels and lymphoid tissues. Vascular changes characterized by congestion, edema, and hemorrhage were found in majority of the organs. Lymphocytolysis in spleen and cecal tonsils was evident. Immunohistochemical studies revealed positive signals mostly in macrophage and lymphocytes. PCR assay was done to confirm the NDV genome, which revealed an amplicon size of 356 bp. The phylogenetic analysis revealed the resemblance of the present isolate (ADS01) with class II genotype NDV XIIIA. The isolate belonged to velogenic NDV as the Minimum Lethal Dose (MLD) and Mean Death Time (MDT) for the present isolate were 10-8 and 41 h, respectively. Thus this study clearly demonstrates that in spite of strict vaccination regime and biosecurity procedures, ND continues to be rampant. Hence it is important to effectively administer the present vaccine in addition to strains matching to the field isolates to provide longer and optimal protection against spreading of virus by means of reducing the extent of viral shedding.

Entities:  

Keywords:  Genotype; Molecular characterization; Pathology; Poultry; Vaccine mismatch; Velogenic viscerotropic Newcastle disease virus

Year:  2018        PMID: 29911151      PMCID: PMC6003064          DOI: 10.1007/s13337-018-0445-5

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  34 in total

1.  Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old.

Authors:  Fabienne Rauw; Yannick Gardin; Vilmos Palya; Sofia Anbari; Sophie Lemaire; Marc Boschmans; Thierry van den Berg; Bénédicte Lambrecht
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

Review 2.  Newcastle disease: a review of field recognition and current methods of laboratory detection.

Authors:  Giovanni Cattoli; Leonardo Susta; Calogero Terregino; Corrie Brown
Journal:  J Vet Diagn Invest       Date:  2011-06-15       Impact factor: 1.279

3.  Clinicopathological characterization in poultry of three strains of Newcastle disease virus isolated from recent outbreaks.

Authors:  L Susta; P J Miller; C L Afonso; C C Brown
Journal:  Vet Pathol       Date:  2010-08-04       Impact factor: 2.221

4.  Avian paramyxovirus type 1 from pigeons: isolate characterization and pathogenicity after chicken or embryo passage of selected isolates.

Authors:  D J King
Journal:  Avian Dis       Date:  1996 Jul-Sep       Impact factor: 1.577

5.  Isolation and characterization of genotype XIII Newcastle disease virus from Emu in India.

Authors:  Vasudevan Gowthaman; Sambhu Dayal Singh; Kuldeep Dhama; Perumal Aurumugam Desingu; Asok Kumar; Yashpal Singh Malik; Muhammad Munir
Journal:  Virusdisease       Date:  2016-06-14

6.  Efficacy of a genotype 2 Newcastle disease vaccine (Avinew) against challenge with highly virulent genotypes 5d and 3d.

Authors:  D G Bwala; C Abolnik; A van Wyk; E Cornelius; S P R Bisschop
Journal:  J S Afr Vet Assoc       Date:  2009-09       Impact factor: 1.474

7.  A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.

Authors:  Shunlin Hu; Huailiang Ma; Yantao Wu; Wenbo Liu; Xiaoquan Wang; Yuliang Liu; Xiufan Liu
Journal:  Vaccine       Date:  2008-12-16       Impact factor: 3.641

8.  Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses.

Authors:  Patti J Miller; Carlos Estevez; Qingzhong Yu; David L Suarez; Daniel J King
Journal:  Avian Dis       Date:  2009-03       Impact factor: 1.577

9.  Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.

Authors:  V Palya; I Kiss; T Tatár-Kis; T Mató; B Felföldi; Y Gardin
Journal:  Avian Dis       Date:  2012-06       Impact factor: 1.577

10.  Patho-epidemiological study on Genotype-XIII Newcastle disease virus infection in commercial vaccinated layer farms.

Authors:  J H Khorajiya; Sunanda Pandey; Priya D Ghodasara; B P Joshi; K S Prajapati; D J Ghodasara; R A Mathakiya
Journal:  Vet World       Date:  2015-03-21
View more
  5 in total

1.  Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.

Authors:  J Fréderique de Graaf; Stefan van Nieuwkoop; Theo Bestebroer; Daphne Groeneveld; Casper H J van Eijck; Ron A M Fouchier; Bernadette G van den Hoogen
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

2.  Molecular characterization of full genome sequences of Newcastle disease viruses circulating among vaccinated chickens in Egypt during 2011-2013.

Authors:  Giang Thi Huong Tran; Serageldeen Sultan; Nabila Osman; Mohamed Ismail Hassan; Hieu VAN Dong; Tung Duy Dao; Tsutomu Omatsu; Yukie Katayama; Tetsuya Mizutani; Yohei Takeda; Haruko Ogawa; Kunitoshi Imai
Journal:  J Vet Med Sci       Date:  2020-04-20       Impact factor: 1.267

3.  Novel variant infectious bursal disease virus suppresses Newcastle disease vaccination in broiler and layer chickens.

Authors:  Linjin Fan; Yulong Wang; Nan Jiang; Mango Chen; Li Gao; Kai Li; Yulong Gao; Hongyu Cui; Qing Pan; Changjun Liu; Yanping Zhang; Xiaomei Wang; Xiaole Qi
Journal:  Poult Sci       Date:  2020-09-28       Impact factor: 3.352

4.  Pathogenesis of Velogenic Genotype VII.1.1 Newcastle Disease Virus Isolated from Chicken in Egypt via Different Inoculation Routes: Molecular, Histopathological, and Immunohistochemical Study.

Authors:  Yassmin El-Morshidy; Walied Abdo; Ehab Kotb Elmahallawy; Ghada Allam Abd El-Dayem; Ahmed El-Sawak; Nagwan El-Habashi; Samah M Mosad; Maha S Lokman; Ashraf Albrakati; Samah Abou Asa
Journal:  Animals (Basel)       Date:  2021-12-15       Impact factor: 2.752

5.  Newcastle Disease Virus Vectored Chicken Infectious Anaemia Vaccine Induces Robust Immune Response in Chickens.

Authors:  Madhan Mohan Chellappa; Sohini Dey; Dinesh Chandra Pathak; Asmita Singh; Narayan Ramamurthy; Saravanan Ramakrishnan; Asok Kumar Mariappan; Kuldeep Dhama; Vikram N Vakharia
Journal:  Viruses       Date:  2021-10-02       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.